Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer. (Q46472442)
Jump to navigation
Jump to search
scientific article published in June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer. |
scientific article published in June 2007 |
Statements
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer (English)
Janice P Dutcher
Kim Margolin
Michael B Atkins
Marc S Ernstoff
John W Smith
Joseph I Clark
Joseph Baar
Jeffrey Sosman
Jeffrey Weber
Chetan Lathia
Janice Brunetti